High Risk of Diabetes and Neurobehavioral Deficits in Individuals With Surgically Treated Hyperinsulinism
- PMID: 26327482
- PMCID: PMC4702456
- DOI: 10.1210/jc.2015-2539
High Risk of Diabetes and Neurobehavioral Deficits in Individuals With Surgically Treated Hyperinsulinism
Abstract
Context: Children with the most common and severe type of congenital hyperinsulinism (HI) frequently require pancreatectomy to control the hypoglycemia. Pancreatectomy increases the risk for diabetes, whereas recurrent hypoglycemia places children at risk of neurocognitive dysfunction. The prevalence of these complications is not well defined.
Objective: The objective was to determine the prevalence of diabetes and neurobehavioral deficits in surgically treated HI.
Design: This was designed as a cross-sectional study of individuals who underwent pancreatectomy for HI between 1960 and 2008.
Outcomes: Diabetes outcomes were assessed through patient interview and medical record review. Neurobehavioral outcomes were assessed through the Adaptive Behavior Assessment System, 2nd edition (ABAS-II), and the Child Behavior Checklist (CBCL).
Results: A total of 121 subjects were enrolled in the study at a median age of 8.9 years (range, 3.5-50.7 y). Thirty-six percent (44 of 121) of subjects had diabetes. Nine subjects developed diabetes immediately after pancreatectomy. Of the remaining 35 subjects who developed diabetes, the median age at diabetes diagnosis was 7.7 years (range, 8 mo to 43 y). In subjects with diabetes, the median hemoglobin A1c was 7.4% (range, 6.5-12.6%), and 38 (86%) subjects required insulin. Subjects with diabetes had a greater percentage of pancreatectomy than subjects without diabetes (95% [range, 65-98] vs 65% [1-98]). Neurobehavioral abnormalities were reported in 58 (48%) subjects. Nineteen (28%) subjects had abnormal ABAS-II scores, and 10 (16%) subjects had abnormal CBCL scores.
Conclusions: Children, who undergo near-total pancreatectomy are at high risk of developing diabetes. Neurobehavioral deficits are common, and developmental assessment is essential for children with HI.
Figures
Similar articles
-
Surgical treatment of congenital hyperinsulinism: Results from 500 pancreatectomies in neonates and children.J Pediatr Surg. 2019 Jan;54(1):27-32. doi: 10.1016/j.jpedsurg.2018.10.030. Epub 2018 Oct 5. J Pediatr Surg. 2019. PMID: 30343978 Free PMC article.
-
Incidence, predictors and outcomes of redo pancreatectomy in infants with congenital hyperinsulinism: a 16-year tertiary center experience.Pediatr Surg Int. 2023 Apr 20;39(1):183. doi: 10.1007/s00383-023-05470-6. Pediatr Surg Int. 2023. PMID: 37079145 Review.
-
Clinical presentation and management of children with diffuse and focal hyperinsulinism: a review of 223 cases.J Clin Endocrinol Metab. 2013 Nov;98(11):E1786-9. doi: 10.1210/jc.2013-2094. Epub 2013 Sep 20. J Clin Endocrinol Metab. 2013. PMID: 24057290 Free PMC article.
-
Characterization of diabetes following pancreatic surgery in patients with congenital hyperinsulinism.Orphanet J Rare Dis. 2018 Dec 22;13(1):230. doi: 10.1186/s13023-018-0970-8. Orphanet J Rare Dis. 2018. PMID: 30577875 Free PMC article.
-
[Congenital hyperinsulinism in newborn and infant].Arch Pediatr. 2005 Nov;12(11):1628-35. doi: 10.1016/j.arcped.2005.07.016. Epub 2005 Sep 28. Arch Pediatr. 2005. PMID: 16198094 Review. French.
Cited by
-
Surgical treatment of congenital hyperinsulinism: Results from 500 pancreatectomies in neonates and children.J Pediatr Surg. 2019 Jan;54(1):27-32. doi: 10.1016/j.jpedsurg.2018.10.030. Epub 2018 Oct 5. J Pediatr Surg. 2019. PMID: 30343978 Free PMC article.
-
Localized islet nuclear enlargement hyperinsulinism (LINE-HI) due to ABCC8 and GCK mosaic mutations.Eur J Endocrinol. 2022 Jun 27;187(2):301-313. doi: 10.1530/EJE-21-1095. Print 2022 Aug 1. Eur J Endocrinol. 2022. PMID: 35674212 Free PMC article.
-
Characterization of the zebrafish as a model of ATP-sensitive potassium channel hyperinsulinism.BMJ Open Diabetes Res Care. 2024 Apr 4;12(2):e003735. doi: 10.1136/bmjdrc-2023-003735. BMJ Open Diabetes Res Care. 2024. PMID: 38575153 Free PMC article.
-
Optimization of a Glucagon-Like Peptide 1 Receptor Antagonist Antibody for Treatment of Hyperinsulinism.Diabetes. 2023 Sep 1;72(9):1320-1329. doi: 10.2337/db22-1039. Diabetes. 2023. PMID: 37358194 Free PMC article.
-
Incidence, predictors and outcomes of redo pancreatectomy in infants with congenital hyperinsulinism: a 16-year tertiary center experience.Pediatr Surg Int. 2023 Apr 20;39(1):183. doi: 10.1007/s00383-023-05470-6. Pediatr Surg Int. 2023. PMID: 37079145 Review.
References
-
- Thomas PM, Cote GJ, Wohllk N, et al. Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy. Science. 1995;268:426–429. - PubMed
-
- Thomas P, Ye Y, Lightner E. Mutation of the pancreatic islet inward rectifier Kir6.2 also leads to familial persistent hyperinsulinemic hypoglycemia of infancy. Hum Mol Genet. 1996;5:1809–1812. - PubMed
-
- De Leon DD, Stanley CA. Pathophysiology of diffuse ATP-sensitive potassium channel hyperinsulinism. In: Stanley CA, De Leon DD, eds. Monogenic Hyperinsulinemic Hypoglycemia Disorders. 1st ed Vol 21 Basel, Switzerland: Karger; 2012:18–29.
-
- Rahier J, Fält K, Müntefering H, Becker K, Gepts W, Falkmer S. The basic structural lesion of persistent neonatal hypoglycaemia with hyperinsulinism: deficiency of pancreatic D cells or hyperactivity of B cells? Diabetologia. 1984;26:282–289. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical